{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:45:51Z","timestamp":1792658751926,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Urban Health"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s11524-010-9438-4","type":"journal-article","created":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T11:24:26Z","timestamp":1266837866000},"page":"592-602","source":"Crossref","is-referenced-by-count":99,"title":["Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment"],"prefix":"10.1007","volume":"87","author":[{"given":"Sandra Ann","family":"Springer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,23]]},"reference":[{"issue":"11","key":"9438_CR1","doi-asserted-by":"crossref","first-page":"e7558","DOI":"10.1371\/journal.pone.0007558","volume":"4","author":"AC Spaulding","year":"2009","unstructured":"Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV\/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2009; 4(11): e7558.","journal-title":"PLoS ONE"},{"issue":"11","key":"9438_CR2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2105\/AJPH.92.11.1789","volume":"92","author":"TM Hammett","year":"2002","unstructured":"Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002; 92(11): 1789\u20131794.","journal-title":"Am J Public Health"},{"issue":"51\u201352","key":"9438_CR3","first-page":"1115","volume":"47","author":"Centers for Disease Control (CDC)","year":"1999","unstructured":"Centers for Disease Control (CDC). Decrease in AIDS-related mortality in a state correctional system\u2014New York, 1995\u20131998. MMWR Morb Mortal Wkly Rep. 1999; 47(51\u201352): 1115\u20131117.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"9438_CR4","volume-title":"Antiretroviral treatment regimen outcomes among HIV-infected prisoners","author":"S Springer","year":"2007","unstructured":"Springer S, Friedland G, Doros G, Pesanti E, Altice FL. Antiretroviral treatment regimen outcomes among HIV-infected prisoners. New Haven: Yale AIDS Program; 2007."},{"issue":"3 Suppl","key":"9438_CR5","first-page":"1S14","volume":"153","author":"L Levasseur","year":"2002","unstructured":"Levasseur L, Marzo J, Ross N, Blatier C. Frequency of re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis. Ann Med Interne. 2002; 153(3 Suppl): 1S14\u20131S19.","journal-title":"Ann Med Interne"},{"issue":"3","key":"9438_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0740-5472(02)00226-X","volume":"22","author":"TW Kinlock","year":"2002","unstructured":"Kinlock TW, Battjes RJ, Schwartz RP. A novel opioid maintenance program for prisoners: preliminary findings. J Subst Abuse Treat. 2002; 22(3): 141\u2013147.","journal-title":"J Subst Abuse Treat"},{"key":"9438_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bsl.2370090303","volume":"9","author":"D Nurco","year":"1991","unstructured":"Nurco D, Hanlon T, Kinlock TW. Recent research on the relationship between illicit drug use and crime. Behav Sci Law. 1991; 9: 221\u2013242.","journal-title":"Behav Sci Law"},{"key":"9438_CR8","volume-title":"A criminal justice system strategy for treating cocaine-heroin abusing offenders in custody","author":"HK Wexler","year":"1988","unstructured":"Wexler HK, Lipton D, Johnson BA. A criminal justice system strategy for treating cocaine-heroin abusing offenders in custody. Washington, DC: US Department of Justice, National Institute of Justice, Office of Communication and Research Utilization; 1988. Available at: www.druglibrary.org\/schaffer\/GOVPUBS\/cjstcha.htm ."},{"issue":"2","key":"9438_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","volume":"356","author":"IA Binswanger","year":"2007","unstructured":"Binswanger IA, Stern MF, Deyo RA, et al. Release from prison\u2014a high risk of death for former inmates. N Engl J Med. 2007; 356(2): 157\u2013165.","journal-title":"N Engl J Med"},{"issue":"8","key":"9438_CR10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jama.2009.202","volume":"301","author":"J Baillargeon","year":"2009","unstructured":"Baillargeon J, Giordano TP, Rich JD, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009; 301(8): 848\u2013857.","journal-title":"JAMA."},{"issue":"12","key":"9438_CR11","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1086\/421392","volume":"38","author":"SA Springer","year":"2004","unstructured":"Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004; 38(12): 1754\u20131760.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"9438_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/003335490512000114","volume":"120","author":"BL Stephenson","year":"2005","unstructured":"Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005; 120(1): 84\u201388.","journal-title":"Public Health Rep"},{"issue":"2","key":"9438_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1258\/095646206775455775","volume":"17","author":"BL Stephenson","year":"2006","unstructured":"Stephenson BL, Wohl DA, McKaig R, et al. Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS. 2006; 17(2): 103\u2013108.","journal-title":"Int J STD AIDS"},{"key":"9438_CR14","volume-title":"Report of the Re-Entry Policy Council: charting the safe adn successful return of prisoners to the community","author":"Council of State Governments (CSG)","year":"2003","unstructured":"Council of State Governments (CSG). Report of the Re-Entry Policy Council: charting the safe and successful return of prisoners to the community. New York: National Institute of Corrections, Justice Center, US Department of Justice, US Department of Labor and the US Department of Health and Human Services (DHHS); NCJ 208479; 2003."},{"key":"9438_CR15","first-page":"361","volume-title":"Prisons: crime and justice: a review of reserach","author":"G Gaes","year":"1999","unstructured":"Gaes G, Flanigan TP, Montiuk L, Stewart L. Adult correctional treatment. In: Tonry M, Petersilia J, eds. Prisons: crime and justice: a review of reserach, vol. 26. Chicago: University of Chicago Press; 1999: 361\u2013425."},{"key":"9438_CR16","volume-title":"Chicago communities and prisoner re-entry","author":"C Visher","year":"2005","unstructured":"Visher C, Farrell J. Chicago communities and prisoner re-entry. Washington: The Urban Institute Justice Policy Center; 2005."},{"key":"9438_CR17","doi-asserted-by":"crossref","unstructured":"Amato L, Minozzi S, Davoli M, Vecchi S, Ferri MM, Mayet S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev. (3):CD005031, 2008.","DOI":"10.1002\/14651858.CD005031.pub2"},{"key":"9438_CR18","volume-title":"Joint position paper on substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention","author":"World Health Organization, United Nations Office On Drugs and Crime, and the Joint United Nations Programme on HIV\/AIDS","year":"2004","unstructured":"World Health Organization, United Nations Office On Drugs and Crime, and the Joint United Nations Programme on HIV\/AIDS. Joint position paper on substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention. Geneva: WHO; 2004."},{"key":"9438_CR19","doi-asserted-by":"crossref","unstructured":"Karberg J, James D. Substance Dependence, Abuse, and Treatment of Jail Inmates, 2002. Washington, D.C. NCJ 209588, 2005.","DOI":"10.1037\/e514862006-001"},{"key":"9438_CR20","unstructured":"Mumola C. Substance abuse and treatment, state and federal prisoners (1997). Bureau of Justice Statistics Special Report, NCJ 172871, USDepartment of Justice, Office of Justice Programs, Washington, DC. pp 1\u201316."},{"issue":"2","key":"9438_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2008.976","volume":"301","author":"RK Chandler","year":"2009","unstructured":"Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009; 301(2): 183\u2013190.","journal-title":"JAMA"},{"issue":"2","key":"9438_CR22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/002204260403400210","volume":"34","author":"D Smith-Rohrberg","year":"2004","unstructured":"Smith-Rohrberg D, Bruce RD, Altice FL. Review of corrections-based therapy for opiate-depenndent patients: Implications for buprenorphine treatment among correctional populations. J Drug Issues. 2004; 34(2): 451\u2013480.","journal-title":"J Drug Issues"},{"issue":"5","key":"9438_CR23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.qai.0000219769.89679.ec","volume":"41","author":"RD Bruce","year":"2006","unstructured":"Bruce RD, Altice FL, Gourevitch MN, Friedland GH. Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. J Acquir Immune Defic Syndr. 2006; 41(5): 563\u2013572.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9438_CR24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","volume":"12","author":"D Sheehan","year":"1997","unstructured":"Sheehan D, Lecrubier Y, Harnett-Sheehan K, et al. Reliability and validity of the MINI International Neuropsychiatric Interview (M.I.N.I.): according to the SCID-P. Eur Psychiatr. 1997; 12: 232\u2013241.","journal-title":"Eur Psychiatr"},{"issue":"3","key":"9438_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","volume":"9","author":"AT McLellan","year":"1992","unstructured":"McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992; 9(3): 199\u2013213.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"9438_CR26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1360-0443.2000.95341912.x","volume":"95","author":"C Rosen","year":"2000","unstructured":"Rosen C, Henson B, Finney J, Moos R. Consistency of self-administered and interview-based Addiction Severity Index composite scores. Addiction. 2000; 95(3): 419\u2013425.","journal-title":"Addiction"},{"issue":"6","key":"9438_CR27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2014II. Addiction. 1993; 88(6): 791\u2013804.","journal-title":"Addiction"},{"issue":"5","key":"9438_CR28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/00952990701522674","volume":"33","author":"MM Copenhaver","year":"2007","unstructured":"Copenhaver MM, Bruce RD, Altice FL. Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence. Am J Drug Alcohol Abuse. 2007; 33(5): 643\u2013654.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"12","key":"9438_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00005053-198812000-00003","volume":"176","author":"D Nurco","year":"1988","unstructured":"Nurco D, Hanlon T, Shaffer J, Kinlock T, Duszynski K, Stephenson P. Differences among treatment clinic types in attitudes toward narcotic addiction. J Nerv Ment Dis. 1988; 176(12): 71.","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"9438_CR30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0093854807309111","volume":"35","author":"TW Kinlock","year":"2008","unstructured":"Kinlock TW, Gordon MS, Schwartz RP, O'Grady KE. A study of methadone maintenance for male prisoners: 3-month postrelease outcomes. Crim Justice Behav. 2008; 35(1): 34\u201347.","journal-title":"Crim Justice Behav"},{"issue":"Suppl 4","key":"9438_CR31","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/508182","volume":"43","author":"LE Sullivan","year":"2006","unstructured":"Sullivan LE, Barry D, Moore BA, et al. A trial of integrated buprenorphine\/naloxone and HIV clinical care. Clin Infect Dis. 2006; 43(Suppl 4): S184\u2013S190.","journal-title":"Clin Infect Dis"},{"key":"9438_CR32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/ADM.0b013e31814b8880","volume":"1","author":"C Garcia","year":"2007","unstructured":"Garcia C, Correa G, Hernandez-Viver A, et al. Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico. J Addiction Med. 2007; 1: 126\u2013132.","journal-title":"J Addiction Med"},{"issue":"Suppl 4","key":"9438_CR33","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1086\/508183","volume":"43","author":"LE Sullivan","year":"2006","unstructured":"Sullivan LE, Bruce RD, Haltiwanger D, et al. Initial strategies for integrating buprenorphine into HIV care settings in the United States. Clin Infect Dis. 2006; 43(Suppl 4): S191\u2013S196.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"9438_CR34","first-page":"9","volume":"152","author":"E Durand","year":"2001","unstructured":"Durand E. Changes in high-dose buprenorphine maintenance therapy at the Fleury-Merogis (France) prison since 1996. Ann Med Interne (Paris). 2001; 152(Suppl 7): 9\u201314.","journal-title":"Ann Med Interne (Paris)"},{"key":"9438_CR35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00002030-200001280-00010","volume":"14","author":"J Moatti","year":"2000","unstructured":"Moatti J, Carrieri M, Spire B, Gastault J, Cassuto J, Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. AIDS And Behavior. 2000; 14: 151\u2013155.","journal-title":"AIDS And Behavior"},{"key":"9438_CR36","volume-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40","author":"Center for Substance Abuse Treatment","year":"2004","unstructured":"Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. Rockville: Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services; 2004."},{"issue":"2\u20133","key":"9438_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.drugalcdep.2007.06.007","volume":"91","author":"EF McCance-Katz","year":"2007","unstructured":"McCance-Katz EF, Moody DE, Morse GD, et al. Interaction between buprenorphine and atazanavir or atazanavir\/ritonavir. Drug Alcohol Depend. 2007; 91(2\u20133): 269\u2013278.","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 4","key":"9438_CR38","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/508187","volume":"43","author":"EF McCance-Katz","year":"2006","unstructured":"McCance-Katz EF, Moody DE, Morse GD, et al. Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine. Clin Infect Dis. 2006; 43(Suppl 4): S224\u2013S234.","journal-title":"Clin Infect Dis."},{"issue":"8","key":"9438_CR39","first-page":"375","volume":"13","author":"AB Douaihy","year":"2003","unstructured":"Douaihy AB, Jou RJ, Gorske T, Salloum IM. Triple diagnosis: dual diagnosis and HIV disease, part 2. AIDS Read. 2003; 13(8): 375\u2013382.","journal-title":"AIDS Read"},{"issue":"8","key":"9438_CR40","first-page":"378","volume":"13","author":"R Bruce","year":"2003","unstructured":"Bruce R, Altice F. Editorial comment: why treat three conditions when it is one patient? AIDS Read. 2003; 13(8): 378\u2013379.","journal-title":"AIDS Read"},{"key":"9438_CR41","volume-title":"Public health behind bars: from prisons to communities","author":"S Springer","year":"2007","unstructured":"Springer S, Altice F. Improving the care for HIV-infected prisoners: an integrated prison-release health model. In: Greifinger R, ed. Public health behind bars: from prisons to communities. New York: Springer; 2007."},{"issue":"4","key":"9438_CR42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11904-005-0011-9","volume":"2","author":"SA Springer","year":"2005","unstructured":"Springer SA, Altice FL. Managing HIV\/AIDS in correctional settings. Current HIV\/AIDS reports. 2005; 2(4): 165\u2013170.","journal-title":"Current HIV\/AIDS reports"},{"issue":"2","key":"9438_CR43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1353\/hpu.0.0030","volume":"19","author":"ND Zaller","year":"2008","unstructured":"Zaller ND, Holmes L, Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008; 19(2): 522\u2013531.","journal-title":"J Health Care Poor Underserved"},{"issue":"9","key":"9438_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","volume":"11","author":"M Connock","year":"2007","unstructured":"Connock M, Juarez-Garcia A, Jowett S, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007; 11(9): 1\u2013171. iii-iv.","journal-title":"Health Technol Assess"}],"container-title":["Journal of Urban Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11524-010-9438-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T01:18:13Z","timestamp":1558833493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11524-010-9438-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,23]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["9438"],"URL":"https:\/\/doi.org\/10.1007\/s11524-010-9438-4","relation":{},"ISSN":["1099-3460","1468-2869"],"issn-type":[{"value":"1099-3460","type":"print"},{"value":"1468-2869","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,23]]}}}